Abstract
Isolated activation of the tongue protrusor muscles is the current technique for treating obstructive sleep apnea (OSA) via functional electrical stimulation. Recent studies, however, have shown marked improvements in upper airway (UAW) patency by co-activating the tongue protrudor and retractor muscles. As such, selective stimulation of the hypoglossal (XII) nerve with a single implantable device presents an attractive alternative for treating OSA. In order to demonstrate the feasibility of such a device, the maximum achievable stimulation selectivity of the Flat Interface Nerve Electrode (FINE) was investigated. The beagle XII nerve was stimulated with an implanted FINE, while the corresponding neural and muscular responses were recorded. The overall performance of the FINE, as defined by the selectivity index (SI), showed a high degree of selectivity at both the fascicular and muscular levels: 0.91 /spl plusmn/ 0.05 (n = 5) and 0.85 /spl plusmn/ 0.03 (n = 4), respectively. The results clearly demonstrate the feasibility of the FINE for selective stimulation of the XII nerve and UAW muscles.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
